Vycor Medical (VYCO) Invested Capital (2010 - 2026)

Vycor Medical (VYCO) has reported Invested Capital for 17 consecutive years, with -$3.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital fell 11.31% year-over-year to -$3.8 million in Q2 2026; TTM through Jun 2026 was -$3.8 million, a 11.31% decrease from a year earlier, with the FY2025 full-year figure at -$3.6 million, down 12.32% from the prior year.
• Invested Capital was -$3.8 million for Q2 2026 at Vycor Medical, down from -$3.8 million in the prior quarter.
• Over five years, Invested Capital peaked at -$2.0 million in Q1 2022 and troughed at -$3.8 million in Q2 2026.
• A 5-year average of -$3.0 million and a median of -$3.1 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital plunged 186.18% in 2022 and dropped 9.77% in 2026, its largest moves.
• Over 5 years, Invested Capital stood at -$2.5 million in 2022, then fell by 15.56% to -$2.9 million in 2023, then fell by 13.04% to -$3.2 million in 2024, then decreased by 12.32% to -$3.6 million in 2025, then decreased by 5.23% to -$3.8 million in 2026.
• The last three Invested Capital figures came in at -$3.8 million (Q2 2026), -$3.8 million (Q1 2026), and -$3.6 million (Q4 2025), per Business Quant data.